Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Milestone Pharmaceuticals Inc. Common Shares (MIST)

Pharmaceutical Preparations

https://www.milestonepharma.com

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT.

1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420
MONTREAL, A8

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/09/2019

Market Cap

69,783,176

Shares Outstanding

33,479,999

Weighted SO

33,483,111

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

DMAC --.--%

MCRB --.--%

IKT --.--%

ONCY --.--%

SCPH --.--%

LIFE --.--%

XFOR --.--%

GRTX --.--%

TERN --.--%

Beta

1.6380

Last Div

0.0000

Range

1.12-3.52

Chg

-0.0400

Avg Vol

138667

Mkt Cap

69783176

Exch

NASDAQ

Country

CA

Phone

15143360444

DCF Diff

2.2280

DCF

-0.8980

Div Yield

0.0000

P/S

-80.3952

EV Multiple

-2.2978

P/FV

2.7105

Div Yield %

0.0000

P/E

-1.7905

PEG

0.6043

Payout

0.0000

Current Ratio

19.1283

Quick Ratio

19.1283

Cash Ratio

2.9039

DSO

-1006.2707

DIO

0.0000

Op Cycle

-1006.2707

DPO

448.1729

CCC

-1454.4436

Gross Margin

1.7028

Op Margin

57.0333

Pretax Margin

56.0091

Net Margin

55.7706

Eff Tax Rate

-0.0188

ROA

-0.5425

ROE

-1.6526

ROCE

-0.5847

NI/EBT

0.9957

EBT/EBIT

0.9820

EBIT/Rev

57.0333

Debt Ratio

0.5838

D/E

1.6292

LT Debt/Cap

0.6171

Total Debt/Cap

0.6197

Int Coverage

-29.4147

CF/Debt

-0.6960

Equity Multi

2.7904

Rec Turnover

-0.3627

Pay Turnover

0.8144

Inv Turnover

0.0000

FA Turnover

-0.4634

Asset Turnover

-0.0097

OCF/Share

-0.5481

FCF/Share

-0.5489

Cash/Share

1.2583

OCF/Sales

41.7773

FCF/OCF

1.0015

CF Coverage

-0.6960

ST Coverage

-63.9555

CapEx Coverage

-664.2089

Div&CapEx Cov

-664.2089

P/BV

2.7105

P/B

2.7105

P/S

-80.3952

P/E

-1.7905

P/FCF

-1.9215

P/OCF

-2.3902

P/CF

-2.3902

PEG

0.6043

P/S

-80.3952

EV Multiple

-2.2978

P/FV

2.7105

DPS

0.0000

Latest Headlines (EST)

Benzinga Dec 27, 09:06 Meta To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday Benzinga Dec 26, 12:20 Crude Oil Rises Over 3%; US Home Prices Increase In October Benzinga Dec 26, 12:20 Crude Oil Rises Over 3%; US Home Prices Increase In October GlobeNewswire Inc. Dec 26, 07:00 Milestone Pharmaceuticals Receives Refusal to File Letter from U.S. FDA for New Drug Application for Etripamil in the Treatment of PSVT

Revenue Product Segmentation